MDL Track
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh
2,348 pending
Medical Device · claims involving Covidien and Parietex hernia mesh failures, adhesion, migration, and revision surgery
Defendant
Covidien LP
MDL / Track
MDL 3029
D. Mass.
Judge
Judge Patti B. Saris
Plaintiffs
2,200 pending
Bellwether / Trial
No verdicts yet
Settlement Status
Track litigations for free. Save this matter, capture notes, and monitor live signals.
Case overview
The first Covidien hernia mesh bellwether trial is scheduled for July 13, 2026, in MDL 3029 (In re Covidien Hernia Mesh Prods. Liab. Litig. No. II), before U.S. District Judge Patti B. Saris in the District of Massachusetts. As of January 2026, over 2,200 cases are pending in the MDL, with additional claims in Massachusetts state court. The litigation centers on allegations that Covidien's polyester-based mesh products—including Parietex, Symbotex, and ProGrip—are defectively designed and cause chronic pain, adhesions, organ perforation, and hernia recurrence requiring revision surgery.
Causation Theory
Plaintiffs allege Covidien's polyester mesh degrades and shrinks over time, causing the microgrip fixation mechanism in ProGrip and the collagen adhesion barrier in Parietex Composite to fail prematurely. This failure allows the rough polyester surface to erode into surrounding tissue, triggering inflammatory responses, dense adhesions, bowel obstructions, and organ perforation. The 1998 JAMA study identified polyester as unsafe for hernia repair, yet Covidien continued marketing Parietex without pre-market human studies.
Case Management Orders
Litigation status
The first Covidien hernia mesh bellwether trial (Patterson v. Covidien) remains scheduled for July 13, 2026 before Judge Patti B. Saris in the District of Massachusetts, after a February 2026 trial date was canceled. A hearing on defendants' motion for summary judgment has been rescheduled to April 2, 2026 per a joint motion.
MDL Track
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh
2,348 pending
State Court Activity
4,700+ cases pending in Massachusetts state court coordinated proceeding
MDL 3029 Leadership
Plaintiff Leadership
Plaintiffs' Lead Counsel
Plaintiff
Defense Leadership
Defense National Counsel
Jessica Wilson
DLA Piper
Geographic exposure
Over 8,000 total claims: 2,200+ in MDL 3029, 6,000+ in Massachusetts state court, and 500 in Minnesota state court. Polyester-based Parietex, Symbotex, and ProGrip devices implicated; polypropylene devices primarily sold overseas.
MDL 3029 (In re Covidien Hernia Mesh Prods. Liab. Litig. No. II) centralized before Judge Patti B. Saris; over 2,200 federal cases pending as of January 2026; first bellwether trial scheduled July 13, 2026 for Symbotex mesh (JPML Transfer Order, MDL No. 3029, June 6, 2022; AboutLawsuits Jan. 9, 2026)
Coordinated state proceeding with over 6,000 claims pending as of June 2022; Covidien LP headquartered in Massachusetts (JPML Transfer Order, MDL No. 3029, June 6, 2022)
Approximately 500 hernia mesh lawsuits pending before Judge James Moore; Medtronic parent company headquartered in Minnesota (Nigh Goldenberg Nov. 2024 update)
Active federal filings in Middle District (Garcia v. Covidien LP, 6:21-cv-01208) and Southern District (Ricci v. Medtronic, Inc., 0:22-cv-60211) transferred to MDL 3029 (JPML Transfer Order Schedule A)
Singletary v. Covidien LP, 2:19-cv-13108 transferred to MDL 3029 (JPML Transfer Order Schedule A)
Federal action opposed centralization; plaintiff litigation active (JPML Transfer Order, MDL No. 3029, June 6, 2022)
Key defendants
Covidien LP
Role: Manufacturer
Headquartered in District of Massachusetts; centralization hub for MDL 3029. Facing ~900 federal suits plus Massachusetts state coordination. Ordered Feb. 2024 to produce unredacted complaint files. Bellwether trials scheduled 2025-2026.
Medtronic, Inc.
Role: Parent/Related Corporate Defendant
Named in MDL 3029 transfer order alongside Covidien entities. Corporate disclosure identifies MEDTRONIC plc as parent. Defense posture coordinated with Covidien LP through unified appearance filings.
Sofradim Productions SAS
Role: Manufacturer/Supplier
French entity named in MDL 3029; produces Parietex mesh components. Transferred into D. Mass. with Covidien defendants. Limited separate docket activity; indemnity posture unclear.
| Defendant | Role | Intelligence Note |
|---|---|---|
| Covidien LP | Manufacturer | Headquartered in District of Massachusetts; centralization hub for MDL 3029. Facing ~900 federal suits plus Massachusetts state coordination. Ordered Feb. 2024 to produce unredacted complaint files. Bellwether trials scheduled 2025-2026. |
| Medtronic, Inc. | Parent/Related Corporate Defendant | Named in MDL 3029 transfer order alongside Covidien entities. Corporate disclosure identifies MEDTRONIC plc as parent. Defense posture coordinated with Covidien LP through unified appearance filings. |
| Sofradim Productions SAS | Manufacturer/Supplier | French entity named in MDL 3029; produces Parietex mesh components. Transferred into D. Mass. with Covidien defendants. Limited separate docket activity; indemnity posture unclear. |
Timeline
First Covidien bellwether trial scheduled
U.S. District Judge Patti B. Saris schedules first bellwether trial for July 13, 2026, in Patterson v. Covidien, involving Symbotex mesh implant failure claims. Trial rescheduled from February 2026. MDL 3029, D. Mass.
February 2026 bellwether trial canceled
Judge Saris cancels February 2026 bellwether trial date, resetting litigation calendar. MDL 3029.
Covidien files summary judgment motion
Covidien and parent Medtronic file motion for summary judgment seeking dismissal of claims affecting approximately 2,100 MDL cases. Company requests 10-day seal on motion to sort confidential documents. MDL 3029, D. Mass.
MDL reaches 1,546 federal cases
Covidien MDL 3029 grows to 1,546 federal cases with over 6,000 additional claims pending in Massachusetts state court. Discovery phase produces over 1.3 million documents on five hernia mesh product lines.
Magistrate orders complaint file production
U.S. Magistrate Judge M. Page Kelly issues stipulated order directing Covidien to produce unredacted 'voluminous collection' of hernia mesh complaint files spanning past decade to expedite discovery. MDL 3029.
Science Day presented to court
Plaintiff and defense counsel present Science Day to Judge Saris on general causation and mesh failure mechanisms. MDL 3029.
JPML forms MDL 3029
Judicial Panel on Multidistrict Litigation consolidates Covidien hernia mesh litigation as MDL 3029, In re: Covidien Hernia Mesh Products Liability Litigation, assigning to U.S. District Judge Patti B. Saris in District of Massachusetts. JPML cites growth from 12 cases (2020) to 85 plaintiffs.
JPML denies initial MDL petition
Judicial Panel on Multidistrict Litigation denies motion to centralize Covidien hernia mesh cases, citing insufficient case numbers. MDL petition renewed 2022.
Statute of limitations
MDL 3029 (In re: Covidien Hernia Mesh Products Liability Litigation) before Judge Patti B. Saris in D. Mass. does not toll state SOLs. First bellwether trial scheduled July 2026; mediation deadline January 14, 2026. No federal preemption applies to state-law failure-to-warn and design defect claims. Cross-jurisdictional screening requires careful accrual analysis for plaintiffs with revision surgeries in multiple states.
Massachusetts
3 years from discovery
Rule: Mass. Gen. Laws ch. 260, § 2A; discovery rule applies per common law
Discovery: Accrues when plaintiff knew or should have known of injury and its causal link to product
MDL 3029 centralized in D. Mass. before Judge Patti B. Saris. First bellwether trial reset for July 2026. Mediation deadline extended to January 14, 2026. No tolling effect from MDL consolidation—state SOL controls.
California
2 years from discovery
Rule: Cal. Code Civ. Proc. § 335.1; discovery rule codified at § 338
Discovery: Accrues when plaintiff discovers or should have discovered injury and probable cause
Large plaintiff pool. No pending revival statute.
Florida
4 years from discovery
Rule: Fla. Stat. § 95.11(3)(a); discovery rule applies per Tischner v. DH Griffin Wrecking Co., 947 So. 2d 1223 (Fla. 2006)
Discovery: Accrues when plaintiff knew or should have known of injury and defendant's potential liability
Substantial Covidien filings. No current revival window.
New York
3 years from discovery
Rule: N.Y. C.P.L.R. § 214(2); discovery rule applies per LaBarbera v. Morgan, 814 N.Y.S.2d 535 (App. Div. 2006)
Discovery: Accrues when plaintiff discovers or should have discovered injury and its cause
Large volume jurisdiction. No revival legislation pending.
Texas
2 years from discovery
Rule: Tex. Civ. Prac. & Rem. Code § 16.003; discovery rule applies per S.V. v. R.V., 933 S.W.2d 1 (Tex. 1996)
Discovery: Accrues when plaintiff knew or should have known of injury and its cause in fact
Significant plaintiff base. No tolling from MDL 3029.
Pennsylvania
2 years from discovery
Rule: 42 Pa. Cons. Stat. § 5524(2); discovery rule applies per Pocono Int'l Raceway, Inc. v. Pocono Produce, Inc., 468 A.2d 468 (Pa. 1983)
Discovery: Accrues when plaintiff knows or reasonably should know of injury and its cause
Active filing state. No pending revival.
Rhode Island
3 years from discovery of wrongdoing
Rule: R.I. Gen. Laws § 9-1-14(b); extended rule per Anthony v. Abbott Labs., 490 A.2d 43 (R.I. 1985)
Discovery: Accrues when plaintiff discovers or should discover manufacturer's wrongdoing—not merely injury
Anthony rule provides extended accrual theory distinct from standard discovery rule. Applies to product liability generally, not Bard-specific. Forum non conveniens risk for non-residents.
| State | SOL | Rule | Discovery Rule | Notes |
|---|---|---|---|---|
| Massachusetts | 3 years from discovery | Mass. Gen. Laws ch. 260, § 2A; discovery rule applies per common law | Accrues when plaintiff knew or should have known of injury and its causal link to product | MDL 3029 centralized in D. Mass. before Judge Patti B. Saris. First bellwether trial reset for July 2026. Mediation deadline extended to January 14, 2026. No tolling effect from MDL consolidation—state SOL controls. |
| California | 2 years from discovery | Cal. Code Civ. Proc. § 335.1; discovery rule codified at § 338 | Accrues when plaintiff discovers or should have discovered injury and probable cause | Large plaintiff pool. No pending revival statute. |
| Florida | 4 years from discovery | Fla. Stat. § 95.11(3)(a); discovery rule applies per Tischner v. DH Griffin Wrecking Co., 947 So. 2d 1223 (Fla. 2006) | Accrues when plaintiff knew or should have known of injury and defendant's potential liability | Substantial Covidien filings. No current revival window. |
| New York | 3 years from discovery | N.Y. C.P.L.R. § 214(2); discovery rule applies per LaBarbera v. Morgan, 814 N.Y.S.2d 535 (App. Div. 2006) | Accrues when plaintiff discovers or should have discovered injury and its cause | Large volume jurisdiction. No revival legislation pending. |
| Texas | 2 years from discovery | Tex. Civ. Prac. & Rem. Code § 16.003; discovery rule applies per S.V. v. R.V., 933 S.W.2d 1 (Tex. 1996) | Accrues when plaintiff knew or should have known of injury and its cause in fact | Significant plaintiff base. No tolling from MDL 3029. |
| Pennsylvania | 2 years from discovery | 42 Pa. Cons. Stat. § 5524(2); discovery rule applies per Pocono Int'l Raceway, Inc. v. Pocono Produce, Inc., 468 A.2d 468 (Pa. 1983) | Accrues when plaintiff knows or reasonably should know of injury and its cause | Active filing state. No pending revival. |
| Rhode Island | 3 years from discovery of wrongdoing | R.I. Gen. Laws § 9-1-14(b); extended rule per Anthony v. Abbott Labs., 490 A.2d 43 (R.I. 1985) | Accrues when plaintiff discovers or should discover manufacturer's wrongdoing—not merely injury | Anthony rule provides extended accrual theory distinct from standard discovery rule. Applies to product liability generally, not Bard-specific. Forum non conveniens risk for non-residents. |
Live intelligence
AI litigation brief
Covidien Hernia Mesh remains established mass tort / active mdl with 45 current signals in the accepted feed.
Overview
The first Covidien hernia mesh bellwether trial (Patterson v. Covidien) remains scheduled for July 13, 2026 before Judge Patti B. Saris in the District of Massachusetts, after a February 2026 trial date was canceled. A hearing on defendants' motion for summary judgment has been rescheduled to April 2, 2026 per a joint motion.
Key developments
Trajectory
Court filings and press coverage are both active in MDL 3029, pointing to sustained litigation pressure rather than a one-off headline cycle. 6 live sources are contributing current context.
Editorial intelligence
MDL 3029 should stay on the lead docket watch because it is the primary consolidation vehicle for Covidien Hernia Mesh.
Generated Jun 13, 2026, 9:00 AM UTC
45 events detected
No recent PubMed signals. Monitoring is active — this section updates automatically.
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket filed in JPML: The plaintiffs claim that Covidien LP and Sofradim Production SAS produced and sold defective hernia mesh devices, leading to injuries related to their defective nature. The involved products include Dextile Anatomical Mesh, Parietene DS Mesh, Parietene Polypropylene Mesh, among others. The lawsuit
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against Sofradim Production SAS, Covidien LP Filing fee: $ 405, receipt number AMADC-11797854 (Fee Status: Filing Fee paid), filed by Jose Martinez. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(Vaughn, C. Brett) (Entered: 06/05/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against Sofradim Production SAS, Covidien LP Filing fee: $ 405, receipt number AMADC-11797816 (Fee Status: Filing Fee paid), filed by Jerry Guerra. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(Vaughn, C. Brett) (Entered: 06/05/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against Sofradim Production SAS, Covidien LP Filing fee: $ 405, receipt number AMADC-11797615 (Fee Status: Filing Fee paid), filed by Christopher Bahr. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(Vaughn, C. Brett) (Entered: 06/05/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT 1:26-cv-12514 against All Defendants Filing fee: $ 405, receipt number AMADC-11790009 (Fee Status: Filing Fee paid), filed by Steven R Floyd. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(King, Robert) (Entered: 06/03/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT 1:26-cv-12511 against All Defendants Filing fee: $ 405, receipt number AMADC-11789442 (Fee Status: Filing Fee paid), filed by Lawrence E Newcomer. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(King, Robert) (Entered: 06/03/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT 1:26-cv-12509 against All Defendants Filing fee: $ 405, receipt number AMADC-11789298 (Fee Status: Filing Fee paid), filed by Angelyn D Johnson. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(King, Robert) (Entered: 06/03/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against Sofradim Production SAS, Covidien LP Filing fee: $ 405, receipt number AMADC-11781638 (Fee Status: Filing Fee paid), filed by Ricardo Lopez, II. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(Vaughn, C. Brett) (Entered: 06/01/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT 1:26-cv-12466 against All Defendants Filing fee: $ 405, receipt number AMADC-11781574 (Fee Status: Filing Fee paid), filed by Frank E. Miller, Jr.. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(King, Robert) (Entered: 06/01/2026)
Covidien Hernia Mesh Products Liability Litigation (No. II)
PACER docket entry from MAD: COMPLAINT against Sofradim Production SAS, Covidien LP Filing fee: $ 405, receipt number AMADC-11781314 (Fee Status: Filing Fee paid), filed by Recon Pride. (Attachments: # 1 Civil Cover Sheet, # 2 Category Form)(Vaughn, C. Brett) (Entered: 06/01/2026)
Workbench
Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.
LexGenius Ranking
94Score
Court, news, and regulatory activity are elevated
Monitoring
Live
monitoring
Last: Jun 13, 2026, 9:00 AM UTC
Next: 11:10
Source Monitoring
PACER
PACER
Google News
MAUDE
PubMed
Event feed
45
events detected
AI Brief
Covidien Hernia Mesh remains established mass tort / active mdl with 45 current signals in the accepted feed.
Overview
The first Covidien hernia mesh bellwether trial (Patterson v. Covidien) remains scheduled for July 13, 2026 before Judge Patti B. Saris in the District of Massachusetts, after a February 2026 trial date was canceled. A hearing on defendants' motion for summary judgment has been rescheduled to April 2, 2026 per a joint motion.
Key developments
PACER court filing on Dec 31: Covidien Hernia Mesh Products Liability Litigation (No. II). ‖ Law360 news on Jun 4: Medtronic Unit Must Face Bellwether Hernia Mesh Claims - Law360. ‖ MAUDE FDA alert on May 31: MAUDE Filing 25341135: SYMBOTEX.
Generated Jun 13, 2026, 9:00 AM UTC
Tracked MDLs
MDL 3029
D. Mass.
Covidien/Parietex hernia mesh